Stay updated with breaking news from Proprietary Laboratory Analysis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cardio Diagnostics’ AI-driven coronary heart disease (CHD) tests have taken another promising step in their evolution. Cardio Diagnostics CDIO, an artificial…
CHICAGO - Cardio Diagnostics Holdings, Inc. , an AI-driven precision cardiovascular medicine company, today announced that the American Medical Association has assigned a dedicated Current...
This is the second CPT PLA code the American Medical Association granted for the Company’s AI-powered coronary heart disease tests. This significant milestone enables the acceleration of...
Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) shares enjoy a growth spurt Tuesday, as the AI-driven precision cardiovascular medicine company, today announced that the American Medical Association (AMA) has assigned a dedicated Current Procedural ...
Obtaining a CPT PLA code marks a key milestone in securing reimbursement from federal and private payers for, and expanding access to the innovative PrecisionCHD test powered by AI and epigenetics ...